Vertex rheumatoid arthritis drug meets study goals
NEW YORK (Reuters) – Vertex Pharmaceuticals Inc said its experimental oral drug for rheumatoid arthritis met the main goals of a mid-stage study.
September 6th, 2011
Posted in
Drug